Comgest Global Investors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-15,000
Closed -$3.65M 60
2017
Q2
$3.65M Hold
15,000
0.09% 41
2017
Q1
$3.58M Buy
15,000
+1,700
+13% +$396K 0.1% 40
2016
Q4
$2.79M Buy
13,300
+4,800
+56% +$994K 0.09% 40
2016
Q3
$1.96M Buy
+8,500
New +$2.08M 0.06% 44

Other funds holding AGN

Comgest Global Investors's AGN Position: Q3 2017 in Review

Comgest Global Investors sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 15,000 shares — an estimated $3.65M sold.

Comgest Global Investors first reported a position in AGN in Q3 2016 and held it in 4 quarters. The position peaked at $3.65M in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Comgest Global Investors reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Comgest Global Investors sold 15,000 Allergan plc shares in Q3 2017, an estimated $3.65M.
  • Comgest Global Investors first reported a position in Allergan plc in Q3 2016 and held it in 4 quarters.
  • Comgest Global Investors's Allergan plc position peaked at $3.65M in Q2 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Comgest Global Investors's 13F filing for Q3 2017, filed 7 Nov 2017.